Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2021-09-24 20:31:35 UTC |
---|
Update Date | 2021-09-24 20:31:36 UTC |
---|
HMDB ID | HMDB0304875 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Zanubrutinib |
---|
Description | Zanubrutinib, also known as brukinsa, belongs to the class of organic compounds known as diphenylethers. These are aromatic compounds containing two benzene rings linked to each other through an ether group. Based on a literature review a significant number of articles have been published on Zanubrutinib. |
---|
Structure | NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1 InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1 |
---|
Synonyms | Value | Source |
---|
7-(1-Acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide | HMDB | Brukinsa | HMDB | (7S)-2-(4-Phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide | MeSH |
|
---|
Chemical Formula | C27H29N5O3 |
---|
Average Molecular Weight | 471.561 |
---|
Monoisotopic Molecular Weight | 471.227039814 |
---|
IUPAC Name | (7S)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide |
---|
Traditional Name | (7S)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1 |
---|
InChI Key | RNOAOAWBMHREKO-QFIPXVFZSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diphenylethers. These are aromatic compounds containing two benzene rings linked to each other through an ether group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Diphenylethers |
---|
Direct Parent | Diphenylethers |
---|
Alternative Parents | |
---|
Substituents | - Diphenylether
- Phenylpyrazole
- Diaryl ether
- Pyrimidinecarboxamide
- Pyrazolopyrimidine
- N-acyl-piperidine
- Phenoxy compound
- Pyrazole-4-carboxamide
- Phenol ether
- Secondary aliphatic/aromatic amine
- Pyrimidine
- Piperidine
- Acrylic acid or derivatives
- Heteroaromatic compound
- Vinylogous amide
- Tertiary carboxylic acid amide
- Pyrazole
- Azole
- Primary carboxylic acid amide
- Carboxamide group
- Amino acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Ether
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Zanubrutinib,1TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4595.3 | Semi standard non polar | 33892256 | Zanubrutinib,1TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3462.2 | Standard non polar | 33892256 | Zanubrutinib,1TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5749.8 | Standard polar | 33892256 | Zanubrutinib,1TMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(N)=O)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4521.6 | Semi standard non polar | 33892256 | Zanubrutinib,1TMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(N)=O)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3161.7 | Standard non polar | 33892256 | Zanubrutinib,1TMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(N)=O)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5641.0 | Standard polar | 33892256 | Zanubrutinib,2TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(=O)N[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4471.2 | Semi standard non polar | 33892256 | Zanubrutinib,2TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(=O)N[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3264.2 | Standard non polar | 33892256 | Zanubrutinib,2TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(=O)N[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5260.4 | Standard polar | 33892256 | Zanubrutinib,2TMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4539.1 | Semi standard non polar | 33892256 | Zanubrutinib,2TMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3548.0 | Standard non polar | 33892256 | Zanubrutinib,2TMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5573.8 | Standard polar | 33892256 | Zanubrutinib,3TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4436.2 | Semi standard non polar | 33892256 | Zanubrutinib,3TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3387.7 | Standard non polar | 33892256 | Zanubrutinib,3TMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C)C3=C(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5078.1 | Standard polar | 33892256 | Zanubrutinib,1TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4801.1 | Semi standard non polar | 33892256 | Zanubrutinib,1TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3625.7 | Standard non polar | 33892256 | Zanubrutinib,1TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5776.7 | Standard polar | 33892256 | Zanubrutinib,1TBDMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(N)=O)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4719.0 | Semi standard non polar | 33892256 | Zanubrutinib,1TBDMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(N)=O)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3459.1 | Standard non polar | 33892256 | Zanubrutinib,1TBDMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(N)=O)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5717.4 | Standard polar | 33892256 | Zanubrutinib,2TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(=O)N[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4803.2 | Semi standard non polar | 33892256 | Zanubrutinib,2TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(=O)N[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3768.6 | Standard non polar | 33892256 | Zanubrutinib,2TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(=O)N[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5356.8 | Standard polar | 33892256 | Zanubrutinib,2TBDMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4858.1 | Semi standard non polar | 33892256 | Zanubrutinib,2TBDMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 3876.0 | Standard non polar | 33892256 | Zanubrutinib,2TBDMS,isomer #2 | C=CC(=O)N1CCC([C@@H]2CCNC3=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5551.8 | Standard polar | 33892256 | Zanubrutinib,3TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4882.5 | Semi standard non polar | 33892256 | Zanubrutinib,3TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 4077.5 | Standard non polar | 33892256 | Zanubrutinib,3TBDMS,isomer #1 | C=CC(=O)N1CCC([C@@H]2CCN([Si](C)(C)C(C)(C)C)C3=C(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(C4=CC=C(OC5=CC=CC=C5)C=C4)=NN32)CC1 | 5166.2 | Standard polar | 33892256 |
| Show more...
---|